Nasal packing with strips of cured pork as treatment for uncontrollable epistaxis in a patient with Glanzmann thrombasthenia - PubMed (original) (raw)
Case Reports
. 2011 Nov;120(11):732-6.
doi: 10.1177/000348941112001107.
Affiliations
- PMID: 22224315
- DOI: 10.1177/000348941112001107
Case Reports
Nasal packing with strips of cured pork as treatment for uncontrollable epistaxis in a patient with Glanzmann thrombasthenia
Ian Humphreys et al. Ann Otol Rhinol Laryngol. 2011 Nov.
Abstract
Objectives: Glanzmann thrombasthenia is a rare disorder of platelet function that may result in life-threatening hemorrhage, particularly from the nasal vaults. Various medical therapies (such as recombinant factor VII, antifibrinolytic agents, and blood transfusions) and surgical therapies (such as nasal packing, electrocautery, laser coagulation, septoplasty, and embolization) have been described with various degrees of success.
Methods: We present a unique case report of a 4-year-old child with known Glanzmann thrombasthenia and two separate episodes of life-threatening epistaxis that were treated successfully by nasal packing with strips of cured pork because of special circumstances.
Results: Cured salted pork crafted as a nasal tampon and packed within the nasal vaults successfully stopped nasal hemorrhage promptly, effectively, and without sequelae. In both applications, the patient had complete cessation of nasal bleeding within 24 hours, and was discharged within 72 hours after treatment.
Conclusions: To our knowledge, this represents the first description of nasal packing with strips of cured pork for treatment of life-threatening hemorrhage in a patient with Glanzmann thrombasthenia.
Similar articles
- Double jeopardy, glomangiopericytoma and Glanzmann thrombasthenia resulting in recurrent epistaxis: a case report.
Hammami E, Fath L, Debry C, Desprez D. Hammami E, et al. Blood Coagul Fibrinolysis. 2024 Mar 1;35(2):62-65. doi: 10.1097/MBC.0000000000001272. Epub 2023 Dec 20. Blood Coagul Fibrinolysis. 2024. PMID: 38179703 - The international, prospective Glanzmann Thrombasthenia Registry: treatment modalities and outcomes of non-surgical bleeding episodes in patients with Glanzmann thrombasthenia.
Di Minno G, Zotz RB, d'Oiron R, Bindslev N, Di Minno MN, Poon MC; Glanzmann Thrombasthenia Registry Investigators. Di Minno G, et al. Haematologica. 2015 Aug;100(8):1031-7. doi: 10.3324/haematol.2014.121475. Epub 2015 May 22. Haematologica. 2015. PMID: 26001793 Free PMC article. - Use of recombinant factor VIIa for bleeding in children with Glanzmann thrombasthenia.
Cağlar K, Cetinkaya A, Aytaç S, Gümrük F, Gürgey A. Cağlar K, et al. Pediatr Hematol Oncol. 2003 Sep;20(6):435-8. Pediatr Hematol Oncol. 2003. PMID: 14631616 - Management of epistaxis.
Kucik CJ, Clenney T. Kucik CJ, et al. Am Fam Physician. 2005 Jan 15;71(2):305-11. Am Fam Physician. 2005. PMID: 15686301 Review. - New Insights Into the Treatment of Glanzmann Thrombasthenia.
Poon MC, Di Minno G, d'Oiron R, Zotz R. Poon MC, et al. Transfus Med Rev. 2016 Apr;30(2):92-9. doi: 10.1016/j.tmrv.2016.01.001. Epub 2016 Jan 30. Transfus Med Rev. 2016. PMID: 26968829 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources